Ebos Group Ltd EJG
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- €10.50
- Day Range
- €10.50–10.50
- 52-Week Range
- €9.65–22.60
- Bid/Ask
- €0.00 / €0.00
- Shares Outstanding
- 209.06M
- Market Cap
- €2.17B
- Volume/Avg
- — / —
Key Statistics
- Price/Earnings (Normalized)
- 19.26
- Price/Sales
- 0.26
- Dividend Yield (Trailing)
- 5.63%
- Dividend Yield (Forward)
- 5.63%
- Dividend Payment Schedule
- Mar, Sep
- Total Yield
- 5.63%
Company Profile
Ebos is the largest pharmaceutical wholesaler across Australia and New Zealand. It services community pharmacies and hospitals, which contribute around 50% and 30% of revenue, respectively. Drug pricing and wholesale margins for PBS medicine are governed by the Australian government's Pharmaceutical Benefits Scheme, or PBS. Wholesale gross margins are capped at 7% for community pharmacy and 10% for hospitals, and ongoing price reform typically results in low-single-digit revenue growth. Aside from pharma distribution, Ebos operates an animal health product wholesale, manufacturing and retail business, as well as undertaking third party logistics services. These segments are smaller contributors to group revenue but due to the unregulated nature are higher-margin operations.
- Sector
- Healthcare
- Industry
- Medical Distribution
- Stock Style Box
- Mid Value
- Total Number of Employees
- 5,000
- Website
- https://www.ebosgroup.com
Competitors
Valuation
Metric | EJG | CAH | MCK |
|---|---|---|---|
Price/Earnings (Normalized) | 19.26 | 23.24 | 25.91 |
Price/Book Value | 1.31 | — | — |
Price/Sales | 0.26 | 0.25 | 0.31 |
Price/Cash Flow | 10.19 | 17.95 | 19.14 |
Price/Earnings
EJG
CAH
MCK
Financial Strength
Metric | EJG | CAH | MCK |
|---|---|---|---|
Quick Ratio | 0.64 | 0.43 | 0.50 |
Current Ratio | 1.16 | 0.88 | 0.90 |
Interest Coverage | 3.35 | 7.64 | 22.07 |
Quick Ratio
EJG
CAH
MCK
Profitability
Metric | EJG | CAH | MCK |
|---|---|---|---|
Return on Assets (Normalized) | 3.32% | 4.78% | 5.95% |
Return on Equity (Normalized) | 9.15% | — | — |
Return on Invested Capital (Normalized) | 7.46% | 48.63% | 56.87% |
Return on Assets
EJG
CAH
MCK
Medical Distribution Industry Comparables
1-Day Chart | Name | Price | Morningstar Rating for Stocks | Capital Allocation | Economic Moat | Market Cap |
|---|---|---|---|---|---|---|
| McKesson Corp MCK | LOCK|MG$!#%& | LOCK|t@bX& | $124B | |||
| Cencora Inc COR | LOCK|%N$mRh | LOCK|??zP | $67B | |||
| Cardinal Health Inc CAH | LOCK|>SWX!p | LOCK|lk%P | $64B | |||
| Sigma Healthcare Ltd SIGGF | — | LOCK|>^BR | $23B | |||
| Henry Schein Inc HSIC | LOCK|CqK^%% | LOCK|D?HS | $10B | |||
| Shanghai Pharmaceuticals Holding Co Ltd ADR SHPMY | — | LOCK|H<h | $8B | |||
| Sinopharm Group Co Ltd SHTDF | — | LOCK|JfX | $7B | |||
| Sinopharm Group Co Ltd ADR SHTDY | — | LOCK|lD | $7B | |||
| Galenica Ltd GALNF | — | LOCK|q?M | $5B | |||
| Medipal Holdings Corp MEPDF | — | LOCK|<V | $4B |
United States